Ophthalmic Pharmacology Practice Questions

Q: Which mydriatic is used in a 3-year-old child for refraction?

1% Atropine ointment. **Explanation:** In pediatric ophthalmology, the gold standard for cycloplegic refraction in children under 5–7 years of age (especially those with strabismus or high hypermetropia) is **Atropine**. This is because children have a very strong ciliary muscle tone (high accommodative power) that must be completely paralyzed to reveal the true refractive error. **Why 1% Atropine Ointment is the Correct Choice:** 1. **Potency:** Atropine is the most potent cycloplegic available, ensuring total paralysis of accommodation. 2. **Safety (Ointment vs. Drops):** In young children, **ointment** is preferred over drops to minimize systemic absorption. Drops can easily drain through the nasolacrimal duct into the highly vascular nasal mucosa, leading to systemic toxicity (Atropine poisoning). Ointment stays in the conjunctival sac longer and has a slower, safer absorption rate. **Analysis of Incorrect Options:** * **1% Atropine Drops:** While chemically effective, they carry a high risk of systemic side effects in toddlers (tachycardia, flushing, fever, and dry mouth) due to rapid nasolacrimal absorption. * **1% Homatropine Drops:** This is a weaker cycloplegic with a shorter duration. It is generally used in older children or for treating anterior uveitis, but it is insufficient for initial refraction in a 3-year-old. * **1% Tropicamide Drops:** This is the shortest-acting mydriatic. While excellent for adult fundus examinations, it provides inadequate cycloplegia for pediatric refraction. **Clinical Pearls for NEET-PG:** * **Standard Regimen:** Atropine 1% ointment is typically applied twice daily for 3 days prior to the refraction ("Atropine 3-day habit"). * **Cycloplegic of Choice by Age:** * 12 years/Adults: Homatropine or Tropicamide. * **Antidote:** In case of Atropine toxicity, the specific antidote is **Physostigmine**.

Q: Which drug can cause macular toxicity when administered intravitreally?

Gentamicin. **Explanation:** **Gentamicin (Option A)** is a potent aminoglycoside antibiotic often used for endophthalmitis. However, it is notorious for causing **dose-dependent macular toxicity** (Aminoglycoside Maculopathy). The underlying mechanism involves the drug's direct toxic effect on the retinal pigment epithelium (RPE) and photoreceptors, leading to **retinal vascular occlusion** (macular infarction). Clinically, this presents as a "cherry-red spot" and permanent vision loss. Due to this narrow therapeutic index, its intravitreal use has largely been replaced by safer alternatives like Amikacin or Ceftazidime. **Why other options are incorrect:** * **Vancomycin (Option B):** It is the gold standard for Gram-positive coverage in endophthalmitis. While it is generally safe for the macula, it is rarely associated with **HORV** (Hemorrhagic Occlusive Retinal Vasculitis), a delayed hypersensitivity reaction, rather than direct dose-dependent toxicity. * **Dexamethasone (Option C):** This is a corticosteroid used to reduce inflammation. Its primary ocular side effects are cataract formation and increased intraocular pressure (steroid-induced glaucoma), not macular toxicity. * **Ceftazidime (Option D):** A third-generation cephalosporin used for Gram-negative coverage. It is significantly less toxic to the retina than Gentamicin and is currently the preferred drug for intravitreal injection in suspected endophthalmitis. **High-Yield Clinical Pearls for NEET-PG:** * **Aminoglycoside Toxicity:** Gentamicin > Tobramycin > Amikacin (Amikacin is the least vestibulotoxic/retinotoxic). * **Classic Sign:** Macular infarction with "pruning" of retinal vessels. * **Standard Endophthalmitis Cocktail:** Intravitreal Vancomycin (1mg/0.1ml) + Ceftazidime (2.25mg/0.1ml).

Q: Which of the following drugs can cause pigment deposition on the cornea?

Digoxin. **Explanation:** The correct answer is **Digoxin**. While many drugs affect the eye, Digoxin is specifically associated with the deposition of fine, dust-like granules on the corneal endothelium. This occurs due to the drug's systemic accumulation, though it rarely affects visual acuity. More famously, Digoxin toxicity causes **Xanthopsia** (yellow-tinted vision) and "snowy" vision due to its inhibitory effect on the Na+/K+ ATPase pump in the retina (photoreceptors). **Analysis of Options:** * **A. Chloroquine:** This drug primarily causes **Vortex Keratopathy** (Cornea Verticillata), which consists of whorl-like epithelial deposits, not generalized pigment deposition. Its most serious side effect is "Bull’s eye maculopathy." * **C. Ranitidine:** This H2-receptor antagonist has no significant documented ocular side effects or corneal deposition patterns relevant to clinical practice or the NEET-PG syllabus. * **D. Amiodarone:** Like Chloroquine, Amiodarone is a classic cause of **Vortex Keratopathy** (Cornea Verticillata). These are golden-brown microdeposits in the basal epithelium of the cornea, seen in nearly all patients on long-term therapy, but they are distinct from the pigmentary pattern seen with Digoxin. **High-Yield Clinical Pearls for NEET-PG:** * **Cornea Verticillata (Whorl Keratopathy) Mnemonic:** **"CHAI-T"** — **C**hloroquine, **H**ydroxychloroquine, **A**miodarone, **I**ndomethacin, and **T**amoxifen (also seen in Fabry’s disease). * **Chlorpromazine:** A high-yield differential for pigment deposition; it causes stellate (star-shaped) opacities on the **anterior lens capsule** and brownish deposits on the corneal endothelium. * **Epinephrine:** Can cause black pigment deposits (adrenochrome) in the conjunctiva.

Q: Which of the following statements is NOT true regarding atropine?

Fast acting. **Explanation:** Atropine is a potent, non-selective muscarinic antagonist. The correct answer is **C (Fast acting)** because Atropine is actually the **longest-acting** cycloplegic and mydriatic available. It takes approximately 30–60 minutes to achieve maximal effect, and its recovery period can last up to **7–14 days**. In contrast, drugs like Tropicamide are preferred for rapid action (20–30 minutes). **Analysis of Options:** * **A. Used as an eye ointment:** True. In children, Atropine is preferred as a 1% ointment rather than drops to minimize systemic absorption through the nasolacrimal duct, reducing the risk of systemic toxicity (e.g., flushing, fever, tachycardia). * **B. Used in refraction in children < 5 years:** True. Atropine is the "Gold Standard" for cycloplegic refraction in children under 5 (and those with accommodative esotropia) because they have a very strong ciliary muscle that requires a potent agent for complete paralysis. * **D. Experimentally used in myopia:** True. Low-dose Atropine (0.01%) is clinically used to slow the progression of myopia in children by preventing axial elongation of the eyeball. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Blocks M3 receptors in the sphincter pupillae (causing mydriasis) and the ciliary muscle (causing cycloplegia). * **Drug of Choice:** For **Iridocyclitis** (to prevent posterior synechiae and provide pain relief by resting the ciliary muscle). * **Contraindication:** Absolute contraindication in **Primary Angle Closure Glaucoma (PACG)**. * **Antidote:** Physostigmine is used for atropine poisoning.

Q: Topical sodium cromoglycate is useful in the treatment of which of the following conditions?

Vernal keratoconjunctivitis. **Explanation:** **Sodium Cromoglycate** is a **mast cell stabilizer**. It works by preventing the degranulation of sensitized mast cells, thereby inhibiting the release of inflammatory mediators like histamine and leukotrienes. **Why Vernal Keratoconjunctivitis (VKC) is correct:** VKC is a Type I (IgE-mediated) hypersensitivity reaction. Since mast cell degranulation is the primary trigger for the itching and inflammation seen in VKC, sodium cromoglycate is highly effective as a prophylactic agent. It is often used as a long-term maintenance therapy to reduce the frequency of acute exacerbations. **Analysis of Incorrect Options:** * **Trachoma:** This is a chronic infectious keratoconjunctivitis caused by *Chlamydia trachomatis*. Treatment requires antibiotics (e.g., Azithromycin). * **Anterior Uveitis:** This is an intraocular inflammation. Management requires topical steroids to control inflammation and cycloplegics (like Atropine) to prevent synechiae and relieve ciliary spasm. * **Phlyctenular Conjunctivitis:** This is a Type IV (delayed) hypersensitivity reaction to endogenous microbial proteins (most commonly Tubercular or Staphylococcal). It is treated with topical steroids and addressing the underlying cause. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Sodium cromoglycate acts by blocking calcium channels, preventing the influx of calcium necessary for mast cell degranulation. * **Lag Period:** It is not effective for acute relief; it takes **5–10 days** to achieve therapeutic effects. * **VKC Triad:** Look for "Cobblestone" papillae, Horner-Trantas dots, and Shield ulcers in clinical vignettes. * **Other Mast Cell Stabilizers:** Nedocromil, Lodoxamide. * **Dual Action Agents:** Olopatadine and Ketotifen (both antihistaminic and mast cell stabilizing) are now preferred for faster symptomatic relief.

Q: Which of the following clinical trials is used to measure the response of a drug in non-infectious uveitis?

Luminate. **Explanation:** The **Luminate trial** (specifically the Luminate study program) evaluated the efficacy and safety of **Intravitreal Fluocinolone Acetonide (YUTIQ)** in patients with chronic, non-infectious uveitis affecting the posterior segment. This trial was pivotal in demonstrating that a sustained-release corticosteroid implant could significantly reduce the rate of uveitis recurrence and improve visual acuity over a 36-month period. **Analysis of Incorrect Options:** * **CATT (Comparison of Age-related Macular Degeneration Treatments Trials):** A landmark study that compared the efficacy of **Ranibizumab** (Lucentis) vs. **Bevacizumab** (Avastin) for the treatment of neovascular (wet) AMD. It concluded that both drugs were highly effective and had similar outcomes. * **ETDRS (Early Treatment Diabetic Retinopathy Study):** This trial established the gold standard for managing diabetic retinopathy. It defined "Clinically Significant Macular Edema" (CSME) and validated the use of **laser photocoagulation** and aspirin in diabetic patients. * **AREDS (Age-Related Eye Disease Study):** This trial evaluated the effect of high-dose **antioxidant vitamins and minerals** (Vitamin C, E, Beta-carotene, Zinc) on the progression of AMD and cataracts. (Note: AREDS2 later replaced Beta-carotene with Lutein/Zeaxanthin). **High-Yield Clinical Pearls for NEET-PG:** * **Non-infectious uveitis** is primarily managed with corticosteroids (topical, periocular, or intravitreal implants like Ozurdex or Retisert/Yutiq). * **MUST KNOW Trials:** * **SCORE:** Steroids vs. Laser for RVO. * **DRCR.net:** Various protocols for Diabetic Macular Edema (DME). * **HORIZON/ANCHOR:** Ranibizumab for AMD.

Q: Which muscarinic agonist is used in the treatment of angle closure glaucoma?

Pilocarpine. **Explanation:** **Pilocarpine** is the correct answer because it is a direct-acting **muscarinic agonist** (parasympathomimetic). In the management of primary angle-closure glaucoma (PACG), pilocarpine acts on the **sphincter pupillae** muscle to cause miosis. This pull on the iris tissue moves it away from the trabecular meshwork, effectively "opening" the angle and allowing the aqueous humor to drain. It also causes contraction of the ciliary muscle, which further facilitates aqueous outflow. **Analysis of Incorrect Options:** * **Neostigmine:** While it is a parasympathomimetic, it is an *indirect-acting* acetylcholinesterase inhibitor. It is primarily used in Myasthenia Gravis and is not a standard treatment for glaucoma due to poor ocular penetration and systemic side effects. * **Brimonidine:** This is a highly selective **alpha-2 adrenergic agonist**. It works by decreasing aqueous production and increasing uveoscleral outflow, but it is not a muscarinic agonist. * **Dipivefrine:** This is a prodrug of **epinephrine** (sympathomimetic). It is contraindicated in narrow-angle glaucoma because it can cause mydriasis, which may precipitate an acute attack. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** While Pilocarpine is used to break an acute attack, the definitive treatment for PACG is **Laser Peripheral Iridotomy (LPI)**. * **Concentration:** 1–2% Pilocarpine is typically used. Higher concentrations should be avoided as they may cause "vascular congestion," worsening the block. * **Side Effects:** Common side effects include **brow ache** (due to ciliary muscle spasm) and **accommodative myopia**. * **Contraindication:** Pilocarpine is generally avoided in **secondary glaucomas** like uveitic glaucoma, as it can increase the risk of posterior synechiae formation.

Q: Which vitamin is used for treating toxic amblyopia?

Hydroxycobalamine. **Explanation:** **Toxic Amblyopia** (specifically tobacco-alcohol amblyopia) is a form of nutritional and toxic optic neuropathy. It is characterized by bilateral, symmetrical visual loss and the presence of **centrocecal scotomas**. **Why Hydroxycobalamine is the Correct Answer:** The underlying pathophysiology involves a deficiency of sulfur-containing amino acids and Vitamin B12, which impairs the detoxification of cyanide (found in tobacco smoke). **Hydroxycobalamine (Vitamin B12b)** is the treatment of choice because it has a high affinity for cyanide. It reacts with cyanide to form **cyanocobalamin**, a non-toxic compound excreted in the urine. Unlike cyanocobalamin, hydroxycobalamine actively scavenges cyanide, making it superior for reversing the optic nerve damage in these patients. **Analysis of Incorrect Options:** * **Vitamin B1 (Thiamine):** While thiamine deficiency causes Beriberi and Wernicke-Korsakoff syndrome (and can contribute to nutritional amblyopia), it does not possess the specific cyanide-binding properties required to treat toxic amblyopia. * **Vitamin B6 (Pyridoxine):** Deficiency is often associated with isoniazid (INH) therapy, leading to peripheral neuropathy, but it is not the primary treatment for toxic optic neuropathy. * **Vitamin B3 (Niacin):** Deficiency leads to Pellagra (Dermatitis, Diarrhea, Dementia). It is not involved in the cyanide detoxification pathway. **High-Yield Clinical Pearls for NEET-PG:** * **Visual Field Defect:** Centrocecal scotoma (a scotoma involving the fixation point and the blind spot). * **Fundus Appearance:** Initially normal; later, temporal pallor of the optic disc may develop. * **Management:** Smoking cessation, alcohol abstinence, and parenteral Hydroxycobalamine (1000 units IM weekly). * **Differential:** Always rule out Leber’s Hereditary Optic Neuropathy (LHON), as tobacco can trigger its onset.

Question 1

Which mydriatic is used in a 3-year-old child for refraction?

Accepted Answer

1% Atropine ointment

Answer

1% Atropine drops

Answer

1% Homatropine drops

Answer

1% Tropicamide drops

Question 2

Which drug can cause macular toxicity when administered intravitreally?

Accepted Answer

Gentamicin

Answer

Vancomycin

Answer

Dexamethasone

Answer

Ceftazidime

Question 3

Which of the following drugs used to treat glaucoma is contraindicated in patients with urine retention?

Accepted Answer

Disopyramide

Answer

Flecainide

Answer

Lidocaine

Answer

Tocainide

Question 4

Which of the following drugs can cause pigment deposition on the cornea?

Accepted Answer

Digoxin

Answer

Chloroquine

Answer

Ranitidine

Answer

Amiodarone

Question 5

Which of the following statements is NOT true regarding atropine?

Accepted Answer

Fast acting

Answer

Used as an eye ointment

Answer

Used in refraction in children less than 5 years old

Answer

Experimentally used in the treatment of myopia

Question 6

Topical sodium cromoglycate is useful in the treatment of which of the following conditions?

Accepted Answer

Vernal keratoconjunctivitis

Answer

Trachoma

Answer

Anterior uveitis

Answer

Phlyctenular conjunctivitis

Question 7

Which of the following clinical trials is used to measure the response of a drug in non-infectious uveitis?

Accepted Answer

Luminate

Answer

CATT

Answer

ETDRS

Answer

AREDS

Question 8

Which muscarinic agonist is used in the treatment of angle closure glaucoma?

Accepted Answer

Pilocarpine

Answer

Neostigmine

Answer

Brimonidine

Answer

Dipivefrine

Question 9

Which vitamin is used for treating toxic amblyopia?

Accepted Answer

Hydroxycobalamine

Answer

Vitamin B1

Answer

Vitamin B6

Answer

Vitamin B3

Question 10

Which of the following drugs is not used in the management of glaucoma?

Accepted Answer

Metoprolol

Answer

Pilocarpine

Answer

Physostigmine

Answer

Timolol

Ophthalmic Pharmacology — MCQs

Ophthalmic Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?